- AliveCor Inc accused Apple Inc AAPL Watch of modifying the heart rate algorithm that made it difficult for third parties to inform a user when to take an ECG or electrocardiogram, Reuters reports.
- The May 2021 lawsuit blamed Apple for gaining an unfair competitive edge over rivals and endangering countless AliveCor users' lives.
- The report added that a U.S. District judge admitted AliveCor, whose SmartRhythm app alerts users to irregular heartbeats, could level antitrust allegations on Apple for allegedly influencing the market for such apps.
- The judge dismissed AliveCor's claim that Apple maintained an illegal monopoly over ECG-capable smartwatches as AliveCor's KardiaBand wristband, which can record ECGs did not compete in that market.
- Price Action: AAPL shares traded higher by 0.25% at $165.79 in the premarket on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in